Ledger.Open graph →
SEC Form D · filed November 3, 2020

Eliem Therapeutics, Inc

Offering
$50.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Redmond, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James Bucher · Redmond, WAExecRobert Azelby · Seattle, WAExec · DirectorSimon Tate · Redmond, WADirectorAndrew Levin · BOSTON, MAExec · DirectorJames Bucher · Redmond, WAExecLiam Ratcliffe · Cambridge, MADirectorAdam Rosenberg · Boston, MADirectorLiam Ratcliffe · Cambridge, MADirectorAndrew Levin · Boston, MAExec · DirectorRobert Azelby · Seattle, WAExec · DirectorAdam Rosenberg · Lake Forest, CADirectorSimon Tate · Redmond, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗